PTSD is a mental health condition that can develop after a shocking, scary or dangerous event. The FDA is deciding whether MDMA, better known as ecstasy, can help.
The U.S. Food and Drug Administration is deciding whether MDMA, a mind-altering compound better known as ecstasy, can be used as a treatment for post-traumatic stress disorder. On Tuesday, an“People may experience a range of reactions after trauma, and most people recover from initial symptoms over time,” NIMH says. But those who continue to experience difficulties may be suffering from PTSD, it adds.describes it as a mental health condition that can develop at any age.
The first category, reexperiencing symptoms, are those in which the traumatic event is relived, such as in flashbacks or dreams. Objects or thoughts can trigger such reminders.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA panel votes against MDMA for PTSD therapyUS health regulator advisers have voted against a therapy based on MDMA for PTSD patients.
Read more »
FDA advisors reject MDMA therapy for PTSD, amid concerns over researchA panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.
Read more »
MDMA Treatment for PTSD Being Considered by FDA AdvisersA pharmaceutical version of MDMA, also known as midomafetamine, could become a new treatment for PTSD ... as advisers for the U.S. Food and Drug Administration are considering whether to recommend it for approval.
Read more »
FDA panel votes against MDMA for PTSD, setting up hurdle to approvalFDA advisers cited a variety of concerns with the trials submitted by Lykos Therapeutics as part of the application.
Read more »
FDA panel rejects first MDMA treatment amid deep concerns about flawed trialsBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
FDA advisors express skepticism as they debate MDMA therapy for PTSDA panel of advisors to the FDA is evaluating the potential use of MDMA for treating PTSD.
Read more »